PPT-Donor Case Studies Optimal Management

HarborUCLA Critical Care Organ Donation Symposium April 12 2010 Brant Putnam MD FACS Trauma Acute Care Surgery Surgical Critical Care HarborUCLA Medical Center What is OPTIMAL donor management. CRT. Charity. Initial Transfer. Anything Left at Death. Payments During Life. Charitable Remainder Trusts. Dr. Russell James. Texas Tech University. Donor. CRT. Charity. Initial Transfer. Anything Left at Death. Why?. Blood . safety starts . by . bleeding safe Blood donors “. Safe Blood starts with me. ”. BTS need to I. mplement adequate donor selection criteria to insure Blood supply safety. BTS need also to insure donor safety. Optimal Management. Harbor-UCLA Critical Care – Organ Donation Symposium. April 12, 2010. Brant Putnam, MD FACS. Trauma / Acute Care Surgery / Surgical Critical Care. Harbor-UCLA Medical Center. What is OPTIMAL donor management?. Phil Clayton. NSW Renal Group. 14 June 2012. Outline. Why study kidney allocation?. Equity vs utility. Current Australian model. Previous work in Australia. US allocation research. Allocation simulations. Donor Retention . Process not a Project. Commitment. Retention . Versus. . Loyalty. How do they relate?. Retain. 1. to . keep possession of. 2. to continue to use, practice, etc.: . to retain an . continuous. . natural. . resource. . extraction.  . with. . increasing. risk in . prices. and stock . dynamics. Professor Dr Peter Lohmander . http://www.Lohmander.com. . Peter@Lohmander.com. Laura Hansen Dean, J.D. Pamela Jones Davidson, J.D.. The . University of Texas . at Austin Davidson Gift Design. Planned Giving Council of Houston. April 24, 2014. Definitions and Standards. Legal Capacity. What Goes Into a Donor Newsletter. Stories about what the donor’s money has allowed the non-profit to accomplish. Stories about challenges the non-profit faces that the donor can help with. Development Department Information for Donors. ECD and DCD Practice. Carl-Ludwig Fischer-Fröhlich, Stuttgart, Germany. frequent co-morbidities in donors . donor derived diseases .  transmission . Mortality / . Morbiditiy. . . pitfalls . Tracy Corcoran. Mary . Bogucki. Lisa Quist. Melissa Kellogg. Major donor development is essential to all organizations. . No matter what size donor base or the size of your organization. Criteria varies . Keith Dalbey, Ph.D.. Sandia National Labs, Dept 1441, Optimization and Uncertainty Quantification. Michael Levy, Ph.D.. Sandia National Labs, Dept 1442, Numerical Analysis and Applications. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the United States Department of Energy’s National Nuclear Security Administration under Contract DE-AC04-94AL85000.. Governing Agencies. Governing agencies . for . processes including donor selection and donor unit processing. U.S. Food and Drug Administration (FDA). Center for Biologics Evaluation and Research (CBER) . NameBruce McFarland Amer HaddadOrganizationUSAID/LebanonOfficeof EducationSocial ImpactPerformanceManagement aLebanon PMSPL IISummaryTo cope with the increased pressure that Syrian refugee children pu Dr Aimun Ahmed living donor lead. DR . mArk. . brady. clinical director. Kquip. meeting, warrington . 31. st. January, 2018. Lancashire Teaching Hospitals . TRANSPLANT SERVICES. Renal Services across Lancashire & South Cumbria.